Blood Glucose Monitoring System Market Size, Share & Industry Analysis, By Device Type (Continuous Glucose Monitoring (CGM) Systems and Self-Monitoring Blood Glucose (SMBG) Systems), By Type (Non-invasive and Invasive), By Modality (Wearable and Non-wearable), By Patient Type (Type 1 Diabetes and Type 2 Diabetes), By Distribution Channel (Retail Sales and Institutional Sales), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI100648

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Growth Rate	CAGR of 6.2% from 2024 to 2032
Unit	Value (USD Billion)
Segmentation	By Device Type Continuous Glucose Monitoring Systems Self-Monitoring Blood Glucose Systems
	By Modality Wearable Non-wearable
	By Type Non-invasive Invasive
	By Patient Type Type-1 Diabetes Type-2 Diabetes
	By Distribution Channel Institutional Sales Retail Sales
	By Geography North America (By Device Type, Type, Modality, Patient Type, Distribution Channel, and Country) U.S. (By Device Type, Type, Modality, Patient Type, and Distribution Channel) Canada (By Device Type, Type, Modality, Patient Type, and Distribution Channel) Europe (By Device Type, Type, Modality, Patient Type, Distribution Channel, and Country/Sub-region) U.K. (By Device Type, Type, Modality, Patient Type, and Distribution Channel) Germany (By Device Type, Type, Modality, Patient Type, and Distribution Channel) France (By Device Type, Type, Modality, Patient Type, and Distribution Channel) Italy (By Device Type, Type, Modality, Patient Type, and Distribution Channel) Spain (By Device Type, Type, Modality, Patient Type, and Distribution Channel) Rest of Europe (By Device Type, Type, Modality, Patient Type, and Distribution Channel) Asia Pacific (By Device Type, Type, Modality, Patient Type, Distribution Channel, and Country/Sub-region) China (By Device Type, Type, Modality, Patient Type, and Distribution Channel) Japan (By Device Type, Type, Modality, Patient Type, and Distribution Channel) India (By Device Type, Type, Modality, Patient Type, and Distribution Channel) Australia (By Device Type, Type, Modality, Patient Type, and Distribution Channel) Korea (By Device Type, Type, Modality, Patient Type, and Distribution Channel) Rest of Asia Pacific (By Device Type, Type, Modality, Patient Type, and Distribution Channel) Rest of the World (By Device Type, Type, Modality, Patient Type, and Distribution Channel)